What did ARCHIMED pay for ZimVie Inc.?

ARCHIMED acquired ZimVie Inc. for $730.0M in 2025 (10.8x EBITDA), equivalent to 1.60x revenue. Target revenue was approximately $452.5M. Target EBITDA was approximately $67.5M.

What does ZimVie Inc. do?

ZimVie Inc. is a medical devices business.

What multiple did ARCHIMED pay for ZimVie Inc.?

10.8x EBITDA and 1.60x revenue, based on disclosed deal value of $730.0M and disclosed financials.

M&A TRANSACTION · 2025

ZimVie Inc. acquired by ARCHIMED

$730.0M· 10.8x EBITDA· 1.60x revenue

Target

ZimVie Inc.

Acquirer

ARCHIMED

Disclosed financials at time of acquisition

Revenue

$452.5M

EBITDA

$67.5M

Deal Value

$730.0M

EV/EBITDA

10.8x

Context

This $730.0M acquisition of ZimVie Inc. by ARCHIMED sits in the medical devices sub-vertical. The 10.8x EBITDA multiple paid in 2025 can be compared against the population median for medical devices transactions of similar size on our Medical Devices valuation hub.

Source

Data sourced from SEC Fairness Opinion — primary source. All figures reflect disclosed values at the time of the acquisition; no estimated or imputed data. Methodology

Value your own medical devices

Get an instant valuation range for your business. Backed by 25,592 real M&A transactions.

Compare your business to the ZimVie Inc. acquisition.

Citation: ExitValue.ai. (2025). ZimVie Inc. acquired by ARCHIMED. https://exitvalue.ai/deals/zimvie-inc-acquired-by-archimed-fairness-opi